.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,100,252

« Back to Dashboard

Details for Patent: 6,100,252

Title: Heterocyclic compounds and their use as angiotensin antagonists
Abstract:
Inventor(s): Naka; Takehiko (Hyogo, JP), Inada; Yoshiyuki (Hyogo, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Filing Date:Dec 08, 1998
Application Number:09/207,044
Claims:1. A compound selected from the group consisting of methyl 2-butyl-1-[[2'-(2-oxo-3H-1,2,3,5-oxathiadiazol-4-yl)biphenyl]methyl]benzim idazole-7-carboxylate; methyl 2-ethoxy-1-[[2'-(2-oxo-3H-1,2,3,5-oxathiadiazol-4-yl)biphenyl]methyl]benzi midazole-7-carboxylate; 2-ethylthio-4-methyl-1-[[2'-(2,3-dihydro-3-oxo-1,2,4-oxadiazol-5-yl)biphen yl-4-yl]methyl]-1H-thieno[3,4-d] imidazole-6-carboxylic acid; 2-butyl-1-[[2'-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5yl)-biphenyl-4-yl]methy l]benzimidazole-7-carboxylic acid; 2-ethylthio-1-[[2'-(2,3-dihydro-2-dihydro-2-oxo-1,3,4-oxadiazol-5-yl)biphe nyl-4-yl]methyl]-4-methylthieno[3,4-d]imidazole-6-carboxylic acid; methyl 2-butyl-1-[[2'-(4,5-dihydro-5-oxo-6H-1,2,4-oxadiazin-3-yl)biphenyl-4-yl]me thyl]benzimidazole-7-carboxylate; 2-butyl-1-[[2'-(2,4-dioxothiazolidin-5-yl)biphenyl-4-yl]methy]benzimidazol e; 2-ethylthio-1-[[2'-(1,4-dihydro-3-trifluoromethyl-5-oxo-1,2,4-triazol-4-yl )biphenyl-4-yl]methyl]thieno[3,4-d]imidazole-4-methyl-6-carboxylic acid; methyl 2-ethylthio-1-[[2'-[1,4-dihydro-3-methyl-5-oxo-1,2,4-triazol-4-yl]biphenyl -4-yl]methyl]thieno[3,4-d]imidazole-4-methyl-6-carboxylate; 1-[[2'-(2,4-4-methyl-3-oxo-1,2,4-triazol-5-yl)biphenyl-4-yl]methyl]-2-ethy lthio-4-methylthieno[3,4-d]imidazole-6-carboxylic acid; 2-ethylthio-1-[[2'-(5-hydroxy-2-methyl-1,2,4-triazol-3-yl)biphenyl-4-yl]me thyl]-4-methylthieno[3,4-d]imidazole-6-carboxylic acid; 1-[[2'-(2,4-dihydro-3-oxo-1,2,4-triazol-5-yl)biphenyl-4-yl]methyl]-2-ethyl thio-4-methylthieno[3,4-d]imidazole-6-carboxylic acid; methyl 2-n-butyl-1-[[2'-(2,4-dioxoimidazolidin-1-yl)biphenyl-4-yl]methyl]benzimid azole-7-carboxylate; and methyl 2-butyl-1-[[2'-(2,4-dioxo-3H-thiazolidin-5-yl)biphenyl-4-yl]methyl]benzimi dazole-7-carboxylate.

2. A compound or a salt thereof of the formula: ##STR71## wherein R.sup.1 is an optionally substituted hydrocarbon residue which is optionally bonded through a heteroatom; R.sup.2 is selected from the group consisting of ##STR72## wherein g is i) --CH.sub.2 --, ii) --NR.sup.9 --, wherein R.sup.9 is hydrogen or (C.sub.1-4) alkyl, iii) --O-- or iv) --S(O).sub.m -- wherein m is an integer of 0 to 2, and >.dbd.Z, >.dbd.Z' and >.dbd.Z" are independently a carbonyl group, a thiocarbonyl group, or an optionally oxidized sulfur atom; X is a direct bond or a spacer having an atomic length of two or less between the ring Y and the ring W; W and Y are independently an optionally substituted aromatic hydrocarbon residue optionally containing a hetero atom or an optionally substituted heterocyclic residue; n is an integer of 1 or 2; and the group of the formula: ##STR73## is a group selected from the class consisting of ##STR74## wherein h is >CH.sub.2, >.dbd.O, >.dbd.S, >S--(O).sub.m (m is an integer of 0 to 2), --NR.sup.9 --(R.sup.9 is hydrogen or lower (C.sub.1-4) alkyl) or --O--;

said group being optionally substituted in addition to the group R.sup.1 and,

wherein (a) is an optionally substituted carbon atom, R.sup.1 and (a) may optionally be bonded to each other to form a group of the formula ##STR75## forming a 5- to 8-membered ring.

3. A compound according to claim 2, wherein R.sup.1 is alkyl, alkenyl, alkynyl or cycloalkyl which may be bound through a group of the formula: --N(R.sup.9)-- wherein R.sup.9 is hydrogen or (C.sub.1-4) alkyl, --O-- or --S--(O).sub.m wherein m is an integer of 0 to 2 and which may be substituted with hydroxy, optionally substituted amino, halogen, (C.sub.1-4) alkoxy, or (C.sub.1-4) alkylthio.

4. A compound according to claim 2, wherein R.sup.1 is aryl or aralkyl which may be bound through a group of the formula: --N(R.sup.9)-- wherein R.sup.9 is hydrogen or (C.sub.1-4) alkyl, --O-- or --S(O).sub.m wherein m is an integer of 0 to 2 and which may be substituted with halogen, nitro, optionally substituted amino, (C.sub.1-4) alkoxy, (C.sub.1-4) alkylthio, or (C.sub.1-4) alkyl.

5. A compound according to claim 2, wherein R.sup.1 is lower (C.sub.1-8) alkyl or (C.sub.2-8) alkenyl which may be bound through a group of the formula: --N(R.sup.9)-- wherein R.sup.9 is hydrogen or (C.sup.1-4) alkyl, --O-- or --S(O).sub.m wherein m is an integer of 0 to 2 and which may be substituted with hydroxy, amino, N-lower (C.sub.1-4) alkylamino, N,N-di (C.sub.1-4) alkylamino, halogen, (C.sub.1-4) alkoxy, or (C.sub.1-4) alkylthio.

6. A compound according to claim 2, wherein R.sup.1 is (C.sub.1-5) alkyl or (C.sub.2-5) alkenyl which may be bound through a group of the formula: --N(R.sup.9)-- wherein R.sup.9 is hydrogen or (C.sub.1-4) alkyl, --O-- or --S(O).sub.m wherein m is an integer of 0 to 2 and which may be substituted with hydroxy, amino, halogen, or (C.sub.1-4) alkoxy.

7. A compound according to claim 2, wherein W and Y are independently phenyl, pyridyl, pyrimidinyl, pyrazinyl, thienyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, isothiazolyl, isooxazolyl, benzofuranyl, isobenzofuranyl, indolizinyl, isoindolyl, 1H-indazolyl, purinyl, 4H-quinolizinyl, isoquinolyl, quinonlyl, phthalazinyl, naphthyridinyl, quinoxalinyl, quinazolinyl, cinnolinyl, or pterdinyl, any of which may be substituted with halogen, nitro, cyano, (C.sub.1-4) alkoxy, or optionally substituted amino.

8. A compound according to claim 2, wherein W is a phenylene group.

9. A compound according to claim 2, wherein Y is a phenyl group.

10. A compound according to claim 2, wherein X is a direct bond, lower (C.sub.1-4) alkylene, --CO--, --O--, --S--, --NH--, --CO--NH--, --O--CH.sub.2 --, --S--CH.sub.2 --, or --CH.dbd.CH--.

11. A compound according to claim 2, wherein X is a direct bond.

12. A compound according to claim 2, wherein n is an integer of 1.

13. A compound according to claim 1, wherein the group of the formula:

##STR76## wherein h is >CH.sub.2, >.dbd.O, >.dbd.S, >S--(O).sub.m (m is an integer of 0 to 2), --NR.sup.9 --(R.sup.9 is hydrogen or (C.sub.1-4) alkyl) or --O-- and R.sup.3 is a group capable of forming an anion or a group convertible thereinto.

14. A compound according to claim 2, wherein the group of the formula(II.sup.b): ##STR77##

15. A compound according to claim 14, wherein the group of the formula (II.sup.b) is a benzimidazole or thienoimidazole structure.

16. A compound according to claim 13, wherein R.sup.3 is optionally esterified or amidated carboxyl, tetrazolyl, trifluoromethanesulfonic amide, phosphoric acid or sulfonic acid, which may be protected with optionally substituted lower alkyl or acyl.

17. A compound according to claim 13, wherein R.sup.3 is a group of the formula: --CO--D wherein D is hydroxy, or optionally substituted alkoxy.

18. A compound according to claim 17, wherein the optionally substituted alkoxy is (C.sub.1-6) alkoxy whose alkyl moiety may be substituted by hydroxy, optionally substituted amino, halogen, (C.sub.1-6) alkoxy, (C.sub.1-6) alkythio or optionally substituted dioxolenyl, or a group of the formula: --O--CH(R.sup.4)--OCOR.sup.5 wherein R.sup.4 is hydrogen, (C.sub.1-6) alkyl, (C.sub.2-6) alkenyl, (C.sub.3-8) cycloalkyl, and R.sup.5 is (C.sub.1-6) alkyl, (C.sub.2-6) alkenyl, (C.sub.3-8) cycloalkyl, (C.sub.1-3) alkyl substituted with (C.sub.3-8) cycloalkyl or aryl, (C.sub.2-3) alkenyl optionally substituted with (C.sub.3-8) cycloalkyl or aryl, aryl, (C.sub.1-6) alkoxy, (C.sub.2-8) alkanyloxy, (C.sub.3-8) cycloalkyloxy, (C.sub.1-3) alkoxy substituted with (C.sub.3-8) cycloalkyl or aryl, (C.sub.2-3) alkenyloxy substituted with (C.sub.3-8) cycloalkyl or aryl, or aryloxy.

19. A compound according to claim 13, wherein R.sup.3 is optionally esterified carboxy.

20. A pharmaceutical composition for antagonizing angiotensin II, which comprises a therapeutically effective amount of a compound according to claim 2 or a pharmaceutically acceptable salt thereof in admixture with a pharmaceutical acceptable carrier, excipient, or diluent.

21. A method for antagonizing angiotension II in a mammal which comprises administering to said mammal a therapeutically effective amount of a compound according to claim 2 or a pharmaceutically acceptable salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc